Inventor · disambiguated record
Stefani Spranger
Also filed as: SPRANGER STEFANI
6 granted patents·2 pending applications·9 citations·filing 2012–2022
74Inventor score
Top patents by PatentIndex Score
8 records- 0184US10034939B2Synergistic combination of immunologic inhibitors for the treatment of cancerUNIV CHICAGO·Filed 2013·Granted Jul 31, 2018·6 cites·11 claims
- 0283US10967060B2Synergistic combination of immunologic inhibitors for the treatment of cancerUNIV CHICAGO·Filed 2018·Granted Apr 6, 2021·1 cites·8 claims
- 0374US10753938B2Beta-catenin inhibitors in cancer immunotherapyUNIV CHICAGO·Filed 2016·Granted Aug 25, 2020·1 cites·15 claims
- 0468US11946936B2Beta-catenin inhibitors in cancer immunotherapyUNIV CHICAGO·Filed 2020·Granted Apr 2, 2024·0 cites·21 claims
- 0566US2021228715A1Synergistic combination of immunologic inhibitors for the treatment of cancerUNIV CHICAGO·Filed 2021·Application pending·0 cites
- 0655US9504692B2Selective inhibition of MALT1 protease by phenothiazine derivativesKRAPPMANN DANIEL·Filed 2012·Granted Nov 29, 2016·1 cites·21 claims
- 0754US12061186B2Compositions and methods for using cross-dressing to enhance anti-tumor immune responsesMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted Aug 13, 2024·0 cites·16 claims
- 0853US2024156911A1Lung-cancer specific t cell dysfunctionMASSACHUSETTS INST TECHNOLOGY·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefani Spranger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →